Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ensaculin (Anseculin), a novel benzopyrone partially substituted with piperazine, showed memory-enhancing effects in passive and conditioned avoidance paradigms in normal and artificially amnesic rodents. It showed neuroprotective activity in a model of NMDA toxicity and neurotrophic effects in primary cultured rat brain cells.Ensaculin can be used for the treatment of dementia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $128 | In Stock | |
5 mg | $320 | In Stock | |
10 mg | $470 | In Stock | |
25 mg | $772 | In Stock | |
50 mg | $1,080 | In Stock | |
100 mg | $1,460 | In Stock | |
500 mg | $2,920 | In Stock |
Description | Ensaculin (Anseculin), a novel benzopyrone partially substituted with piperazine, showed memory-enhancing effects in passive and conditioned avoidance paradigms in normal and artificially amnesic rodents. It showed neuroprotective activity in a model of NMDA toxicity and neurotrophic effects in primary cultured rat brain cells.Ensaculin can be used for the treatment of dementia. |
Targets&IC50 | α1B:9.3 nM, α1A:4.7 nM, D3:27.7 nM, 5-HT2:>100 nM, D4:277 nM, 5-HT1A:8 nM, α:>100 nM, D2:16.6 nM |
In vivo | Ensaculin (0.1, 1 and 10 mg/kg; i.p.; Wistar rats; 20 min after the onset of glutamate perfusion) significantly antagonized the formation of 2,3-DHBA, to values of 60.5% and 56.7% of control levels, respectively. Ensaculin may be useful in the treatment of neurodegenerative disorders associated with elevated hydroxyl free radicals and excitotoxicity.[1] |
Alias | Anseculin |
Molecular Weight | 452.54 |
Formula | C26H32N2O5 |
Cas No. | 155773-59-4 |
Smiles | CC=1C=2C(=CC(OC)=C(OCCCN3CCN(CC3)C4=C(OC)C=CC=C4)C2)OC(=O)C1C |
Storage | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 42.6 mg/mL (94.03 mM ), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.